In (Schnute et al, 2012), 7 days of treatment with PF-543 decreased S1P levels tenfold but only increased sphingosine levels twofold in the single cell line evaluated, a head and neck cancer cell line with exceptionally high SK1 activity. This evidence concerns the gene SPHK1 and head and neck cancer.